Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2500 of 3284 entries
View as:

Barrett's Esophagus - 315 - 3 Way Cross Over

Phase: N/A Priority: Normal
NCT ID: NCT00637988 Org: User:
Start: 04/30/02 End: 06/30/03 Due: 06/30/04

A Phase I Study of MEDI9447 (Oleclumab) in Japanese Patients

Phase: N/A Priority: Normal
NCT ID: NCT03736473 Org: User:
Start: 11/07/18 End: 06/19/19 Due: 06/19/20

Collection of Efficacy and Safety Data of Chinese Patients Who Have Received Faslodex 250mg Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01425294 Org: User:
Start: 08/01/11 End: 01/30/16 Due: 01/30/17

A Comparison of Seroquel vs. Risperidone in Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00034905 Org: User:
Start: 07/31/01 End: 09/30/02 Due: 09/30/03

Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of Ultra Low Doses of Dapagliflozin in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01135446 Org: User:
Start: 05/31/10 End: 06/30/10 Due: 06/30/11

A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04351555 Org: User:
Start: 12/16/20 End: 06/13/29 Due: 06/13/30

To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole

Phase: N/A Priority: Normal
NCT ID: NCT01249651 Org: User:
Start: 11/30/10 End: 06/30/11 Due: 06/30/12

Study to Investigate the Safety, Tolerability and Activity of AZD5069 When Given as a Single Dose to Healthy Male and/or Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00953888 Org: User:
Start: 07/31/09 End: 12/31/09 Due: 12/31/10

Patient-reported Outcomes in Real-world Use of Benralizumab in Patients With Severe Eosinophilic Asthma in Belgium

Phase: N/A Priority: Normal
NCT ID: NCT04221802 Org: User:
Start: 12/23/19 End: 05/13/24 Due: 05/13/25

Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey

Phase: N/A Priority: Normal
NCT ID: NCT00660712 Org: User:
Start: 03/31/08 End: 03/31/09 Due: 03/31/10

A Study to Investigate the Pharmacokinetics of AZD2389 in Healthy Participants When Administered Alone and in Combination With Quinidine

Phase: N/A Priority: Normal
NCT ID: NCT06974565 Org: User:
Start: 05/12/25 End: 06/30/25 Due: 06/30/26

Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00888082 Org: User:
Start: - End: 04/30/12 Due: 04/30/13

Epidemiological and Scientific Evaluation of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or m

Phase: N/A Priority: Normal
NCT ID: NCT00997230 Org: User:
Start: 09/30/09 End: 10/31/12 Due: 10/31/13

RELEVANCE - RWE Study in Unresectable Non-Small Cell Lung Cancer (Stage III) in Canada

Phase: N/A Priority: Normal
NCT ID: NCT05933044 Org: User:
Start: 11/19/21 End: 08/31/22 Due: 08/31/23

Study of AZD9291 Plus MEDI4736 Versus AZD9291 Monotherapy in NSCLC After Previous EGFR TKI Therapy in T790M Mutation Positive Tumours

Phase: N/A Priority: Normal
NCT ID: NCT02454933 Org: User:
Start: 07/15/15 End: 06/21/23 Due: 06/21/24

The Effect of Multiple Doses of Epanova® on the Multiple-Dose Pharmacokinetics of Simvastatin in Healthy Normal Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01486433 Org: User:
Start: 11/30/11 End: 03/31/12 Due: 03/31/13

Excretion of Radiolabelled AZD0837

Phase: N/A Priority: Normal
NCT ID: NCT00812643 Org: User:
Start: 01/31/09 End: 02/28/09 Due: 02/28/10

Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal

Phase: N/A Priority: Normal
NCT ID: NCT05169619 Org: User:
Start: 04/30/21 End: 03/06/24 Due: 03/06/25

To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401)

Phase: N/A Priority: Normal
NCT ID: NCT00659841 Org: User:
Start: 12/31/03 End: 02/28/05 Due: 02/28/06

The Prevalence of Sympathetic Overactivity in Primary Hypertensive Patients.

Phase: N/A Priority: Normal
NCT ID: NCT01295021 Org: User:
Start: 02/28/11 End: 02/29/12 Due: 02/28/13

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT06996782 Org: User:
Start: 05/23/25 End: 12/27/28 Due: 12/27/29

A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.

Phase: N/A Priority: Normal
NCT ID: NCT06742853 Org: User:
Start: 12/20/24 End: 08/11/25 Due: 08/11/26

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD7503 in Japanese Healthy Participants.

Phase: N/A Priority: Normal
NCT ID: NCT06093542 Org: User:
Start: 10/25/23 End: 03/20/24 Due: 03/20/25

Bioequivalence Study Comparing Arimidex Tablet and Anastrozole ODF in Japanese Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01568281 Org: User:
Start: 04/30/12 End: 06/30/12 Due: 06/30/13

A Study to Assess Safety and Tolerability as Well as Absorption and Excretion of TC-5214 in Medically Stable Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01239771 Org: User:
Start: 01/31/11 End: 05/31/11 Due: 05/31/12